Invention Grant
- Patent Title: Enhancement of MSC immunomodulatory properties by treprostinil
-
Application No.: US15790666Application Date: 2017-10-23
-
Publication No.: US11571444B2Publication Date: 2023-02-07
- Inventor: Roger Marquez Ilagan , Sarah Hogan , John B. Cheadle
- Applicant: United Therapeutics Corporation
- Applicant Address: US MD Silver Spring
- Assignee: United Therapeutics Corporation
- Current Assignee: United Therapeutics Corporation
- Current Assignee Address: US MD Silver Spring
- Agency: Foley & Lardner LLP
- Main IPC: A61K35/28
- IPC: A61K35/28 ; A61K31/192 ; C12N5/0775

Abstract:
Provided are methods for treating or preventing vasculopathy comprising administering to a subject in need thereof , ac composition comprising a mesenchymal stem cell (MSC), or a part of a culture medium that has been in contact with the MSC and comprises one or more components of the MSC, or an exosome derived from the MSC. Pharmaceutical compositions suitable for such treatment is also provided.
Public/Granted literature
- US20180110807A1 ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINIL Public/Granted day:2018-04-26
Information query
IPC分类: